Triptans are effective medicines used to treat migraine headaches. They significantly reduce pain within two hours for most people. Complete relief is less common, but the likelihood may be greater if ...

July 7, 2010 (Los Angeles, California) — Patients with migraine who have not experienced relief with sumatriptan may benefit from another 5-hydroxytryptamine receptor agonist, report researchers ...

Acute treatment of migraine with a combination tablet containing sumatriptan and naproxen has better efficacy than monotherapy with either drug alone, without increased adverse events Brandes et al.

This prevalence stands in contrast to the limited research that addresses prevention or treatment of postdischarge headache recurrence. Although dexamethasone, naproxen, and tryptamine-based drugs ...

Trigeminal neuralgia is typically treated with chronic therapy, but patients occasionally require treatment for acute pain. Now, subcutaneous sumatriptan (Imitrex) and intranasal lidocaine have each ...

Subcutaneous sumatriptan 6 mg is undeniably an excellent treatment of migraine. However, some patients have avoided using 6 mg sumatriptan because of unpleasant or unwanted side effects. To evaluate ...

Tosymra Nasal Spray 10 mg is a Proprietary Acute Migraine Treatment Approved Under the 505(b)2 Pathway Based on Bioequivalence to Imitrex (sumatriptan) Injection 4 mg GlaxoSmithKline Recently Notified ...

PITTSBURGH, Aug. 10 /PRNewswire-FirstCall/ -- Mylan Inc. (NASDAQ: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. has received approval from the U ...

Sumatriptan (as succinate) 4mg/0.5mL, 6mg/0.5mL; for SC inj. Imitrex Injection is supplied as a clear, colorless to pale yellow, sterile, nonpyrogenic solution as either prefilled syringe and/or ...

SAN DIEGO, Dec. 10, 2013 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company developing and commercializing products for the treatment of central nervous system (CNS) disorders ...